Unit 4 Flashcards

1
Q

4 non-contraceptive benefits of combination oral contraceptives

A
  1. decrease the risk of ovarian, endometrial, and colon cancer
  2. decrease the risk of benign breast disease and ovarian cysts
  3. decrease the risk of endometriosis, fibroids, ovulation pain, PMS/PMDD, cramps, migraines, and anemia
  4. may improve acne and hirsutism (excessive hair growth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how to start a patient on oral contraceptives (2)

A
  1. start the pill pack on the first day of menses or start the Sunday after menses (if you want to avoid weekend menstruation)
  2. use backup form of birth control for the first 7 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what oral contraceptive to order if the patient has a hx of smoking(4)

A

progestin only
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what oral contraceptive to order if the patient is over 35

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what contraceptive to order if the patient has uncontrolled HTN

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what oral contraceptive to order if the patient has abnormal vaginal bleeding

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what oral contraceptive to order if the patient has DM with vascular complications

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what oral contraceptive to order if the patient has DVD

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what oral contraceptive to order if the patient has hx of PE

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what oral contraceptive to order if the patient has ischemic heart disease

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what oral contraceptive to order if the patient has HA with focal neuro symptoms

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what oral contraceptive to order if the patient has hx of breast CA

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what oral contraceptive to order if the patient has active hepatitis or cirrhosis

A

progestin only OCP
depo-provera
IUD
nexplanon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 contraindications of nexplanon

A

hepatic disease
thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what oral contraceptive to order if the patient has endometriosis

A

monophasic continuous therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what oral contraceptive to order if the patient is post-partum/lactating

A

progesterone-only minipill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what oral contraceptive to order if the patient is noncompliant

A

depo provera
subdermal implant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what oral contraceptive to order if the patient has breakthrough bleeding in first half of cycle

A

change to pill with high estrogen content in 1st half of cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what oral contraceptive to order if the patient has breakthrough bleeding in second half of cycle

A

change to pill with high progestin content in 1st half of cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what oral contraceptive to order if the patient is adolescent, perimenopausal, postpartum, non-lactating, and no medical risks

A

any OCP <50mcg EE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

3 serious side effects of oral contraceptive pills

A

increased risk of
VTE
MI/stroke (esp >35 and smoker)
liver disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

7 less serious side effects of oral contraceptive pills

A

breast tenderness
N/V
HA
bloating
acne
mood changes
spotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

3 side effects associated with progestin-only contraceptive pills

A

weight gain
fluid retention
acne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what type of contraceptive is depo provera and frequency

A

progestin-only
IM injection
q13 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when to initiate depo provera

A

within first 5 days after menses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what to do if a patient presents after 13 weeks for their depo provera shot

A

pregnancy test before administering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

6 SE of depo provera

A

wt gain
HA
dizziness
nervousness
amenorrhea
irregular bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

depo provera education

A

can cause reversible loss of bone mineral density– educate the patient to increase calcium and vitamin D intake along with regular exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

depo provera reversal

A

70% of women can conceive within the first year and 90% within the first 2 years. Discuss family planning before initiating and continuing therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

who is depo provera a safer option for? (5)

A

CV disease
stroke
VTE
PVD
sickle cell disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what type of contraceptive is an IUD

A

progestin-only OR
non hormonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

IUD maintanence

A

check strings after each period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

who is an IUD a good choice for

A

dysmenorrhea
menorrhagia
anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

8 SE of IUD

A

PID
ectopic pregnancy
uterine perforation
expulsion
ovarian cysts
irregular bleeding
amenorrhea
pelvic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

4 contraindications of IUD

A

suspected pregnancy
uterine abnormalities
PID
unexplained vaginal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

which contraceptive method has decreased efficacy in patients with high BMI

A

xulane transdermal patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

xulane transdermal patch risk

A

increased risk of VTE if pt over 198lbs or BMI >30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

when to prescribe emergency contraception

A

within 5 days of unprotected sex (3 is best)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

how does emergency contraception work

A

stops ovulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what to do if no period within 21 days after use of emergency contraception

A

pregnancy test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

emergency contraceptive drug options

A

Copper IUD
Levonorgestrel
Ulipristal acetate
Yuzpe regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

considerations for levonorgestrel (2)

A

<94% effectiveness
less effective in women over 165 lbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

considerations for ulipristal acetate (2)

A

98% effective
less effective in women over 195 lbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

considerations for yuzpe regimen (2)

A

less effective
causes N/V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

first line therapy for VVC

A

OTC topical 1-7 days (monistat) +
1x fluconazole PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

second line therapy for VVC

A

cultures for recurrent VVC
7-14 topical
PO fluconazole q72h x3 doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

third line therapy for VVC

A

referral
10-14 days topical
PO with maintenance therapy with fluconazole 1x per week for 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

first line therapy for trichomonas

A

metronidazole or tinidazole 2g single dose OR
metronidazole 500mg BID x7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

education for trichomonas

A

must also treat sex partners
avoid sex until therapy is completed and symptom-free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

second line therapy for trichomonas

A

referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

first line treatment for bacterial vaginosis

A

PO flagyl
topical clinda cream
flagyl gel intravaginally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

education for bacterial vaginosis treatment (3)

A
  1. flagyl can cause N/V if alcohol ingested during treatment or within 72 hours after stopping
  2. avoid tight-fitting clothes, allow vaginal ventilation
  3. avoid douching or other products that may alter pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

hormone therapy for patients with a uterus

A

progestin + systemic estrogen (oral or transdermal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

risk of taking estrogen alone for patients with a uterus

A

endometrial hyperplasia
increased risk of endometrial CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

hormone therapy for patients without a uterus

A

can use estrogen alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

contraindications of hormone therapy (6)

A
  1. estrogen-dependent neoplasia
  2. thrombophlebitis/thromboembolic disorder
  3. pregnancy
  4. undx vaginal bleeding
  5. uncontrolled HTN
  6. acute liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

monitoring for patients taking hormone therapy (5)

A
  1. F/u 4-8 wks after therapy initiation, then q3-6 mo
  2. review the decision to continue yearly
  3. continue mammograms, PAPs, and DEXA scans
  4. ht/wt, lipids, BP, breast exam, full pelvic exam
  5. d/c 1-3 years after menopause, taper gradually to reduce rebound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

risk of taking hormone therapy for over 3-5 years

A

breast CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

best treatment for vasomotor symptoms when hormone therapy is contraindicated (4)

A

SSRI/SNRI
gabapentin
clonidine
progestin only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

treatment for genitourinary syndrome of menopause (hormone therapy) (3)

A

low dose vaginal estrogen OR
transdermal estrogen OR
ospemifene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

treatment for genitourinary syndrome of menopause (non hormonal)

A

vaginal lubricant and moisturizers and continued sexual intercourse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

6 antibiotics used for PID

A

cephalosporins
Clindamycin
doxycycline
gentamycin
Metronidazole
probenecid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

2 cephalosporins used for PID

A

ceftriaxone
cefotetan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

2 SE of cephalosporins

A

colitis
PCN allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

2 SE of doxy

A

photosensitivity
hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

when to use clinda for PID

A

tubo-ovarian abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

3 SE of gentamycin

A

renal/oto/neurotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

3 SE of probenecid

A

GI upset
uric acid
kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

when to avoid probenecid

A

avoid with ASA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

contraindications of flagyl

A

pregnancy/lactation
with alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

SE of flagyl (1)

A

phototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

how to treat severe PID

A

parenteral therapy with transition to PO within 24-48 hrs after symptom improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

treatment of gonorrhea in patients allergic to cephalosporins

A

gentamycin IM + azithromycin PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

3 medications for suppressive therapy in patients with genital herpes

A

acyclovir
valacyclovir
famiciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

2 medications for suppressive therapy in pregnant patients with genital herpes

A

acyclovir
valacyclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

acyclovir considerations

A

low bioavailability
more frequent dosing
more difficult compliance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

doxycycline contraindication

A

2nd-3rd trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

treatment for pregnant patients with chlamydia

A

azithromycin 1g PO x1 dose (amox. as alt)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

considerations for pregnant patients with chlamydia

A

retest 3-4 weeks after treatment and again after 3 months to make sure it is not passed to the child

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

3 patient-applied treatments for genital warts

A
  1. Imiquimod
  2. Podofilox
  3. Sinecatechins (green tea extract)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

education for imiquimod

A

apply with finger at bedtime for up to 16 weeks
wash off in the morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

education for podofilox

A

apply solution with cotton swab or gel with finger BID x3days, 4 days off, repeat for 4 cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

education for sinecatechins

A

apply up to 3x/day for up to 16wks
do NOT wash off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

treatment for syphilis in pregnant patients with allergy to PCN

A

PCN G is only effective treatment during pregnancy
must desensitize (allows temporary tolerance) mom to PCN and treat with PCN G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

first line treatment of ED (4)

A

phosphodiesterase-5 inhibitors:
Cialis
Vardenafil
Sildenafil
Avanafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

contraindiactions of phosphodiesterase-5 inhibitors (10)

A

nitrates
alpha-blockers
unstable angina
hypotension
uncontrolled HTN
recent stroke
arrhythmias
MI w/in 6 mo
severe HF
renal/hepatic failure

87
Q

cialis usage

A

long duration of action and avoids the need to plan for sex
30 min onset

88
Q

vardenafil usage

A

60 min onset
decreased absorption with fatty foods

89
Q

sildenafil usage

A

take 30-60 min before sex
3-5 hr half-life
decreased absorption with fatty foods

90
Q

avanafil onset and half-life

A

take 15 mins before sex
half-life 5-10 hours

91
Q

MOA of antimuscarinics

A

inhibit binding of ACH at muscarinic receptors M3 on detrusor smooth muscle cells, causing relaxation and increasing bladder filling capacity

92
Q

SE of antimuscarinics

A

anticholinergic SE (can’t pee, see, spit, shit)

93
Q

contraindications of antimuscarinics

A

narrow-angle glaucoma
urinary retention
CYP450 drugs

94
Q

which formulation of antimuscarinics is preferred

A

ER

95
Q

first line treatment of uncomplicated UTI

A

Bactrim
Nitrofurantoin (macrobid)** best
Fosfomycin

96
Q

first line medications to avoid for uncomplicated UTI in patients with renal dysfunction

A

bactrim and nitrofuratoin

97
Q

nitrofurantoin pregnancy considerations

A

do not use in 1st trimester or last 30 days

98
Q

bactrim pregnancy considerations

A

do not use

99
Q

first line treatment for uncomplicated UTI in pregnant patients

A

fosfomycin

100
Q

second line treatment for uncomplicated UTI

A

bactrim
fluroroquinolones

101
Q

flurorquinolones black box warning

A

achilles tendon rupture

102
Q

fluroquinolones pregnancy considerations

A

weight risk vs benefit

103
Q

third line treatment of complicated UTI for males or post-menopausal women

A

levaquin

104
Q

third line treatment of complicated UTI for pregnant women

A

amox
keflex
nitrofurantoin/bactrim (not in 1st trimester or last 30 days)

105
Q

why is treatment required for prostatitis

A

inflammation of the prostate can restrict the urinary outflow via the urethra

106
Q

S/sx of prostatitis (8)

A

pain
difficulty emptying bladder
weak stream
nocturia
fever
malaise
pain on ejaculation
rectal pain

107
Q

first line treatment of prostatitis

A

fluoroquinolones best choice
bactrim

108
Q

second line treatment of prostatitis

A

doxy
azithromycin
clarithromycin

109
Q

how long is abx therapy for prostatitis

A

4-6 weeks
may need up to 12 wks due to poor tissue penetration

110
Q

treatment of BPH

A
  1. alpha-adrenergic blockers
  2. 5-alpha-reductase inhibitors
  3. combo of 1+2
  4. PDE-5 inhibitors (cialis)
  5. Supplements
111
Q

3 supplements for BPH

A

saw palmetto
ptgeum
zinc

112
Q

MOA of alpha blockers

A

relax smooth muscle of the prostate and bladder neck to decrease bladder resistance to urinary outflow

113
Q

SE of alpha blockers (7)

A

hypotension
ortho hypotension
fluid retention
HA
dizziness
weakness
drowsiness

114
Q

who to avoid giving doxazosin to

A

CHF and renal failure pts

115
Q

contraindication of tamsulosin

A

prostate CA

116
Q

contraindication/consideration for silodosin (rapaflo)

A

hepatic/renal impairment
selective alpha antagonist so minimizes BP effects

117
Q

MOA of 5-alpha reductase inhibitors

A

blocks 5-alpha reductase, weakening prostate growth by inhibiting the conversion of testosterone to DHT

118
Q

5-alpha-reductase inhibitor suffix

A

-eride

119
Q

alpha blocker suffix

A

-osin

120
Q

SE of finasteride (2)

A

impotence
decrease libido

121
Q

SE of dutasteride (3)

A

ortho hypotension
priapism
risk of prostate CA

122
Q

monitoring for BPH treatment

A

monitor BP during first 2 weeks
keep open discussion about sexual health
AUA symptom score (3-4 point improvement is significant)

123
Q

how to treat an AUA symptom score of 7

A

pharm treatment

124
Q

how to treat an AUA symptoms score of <7

A

lifestyle mod

125
Q

risk factors with long term use of agents that treat GERD

A

reduced efficacy and tolerance with H2RAs

126
Q

treatment regimen for NSAID-induced PUD

A
  1. find another pain management modality
  2. use enteric-coated NSAIDs, take with meals, add misoprostol, switch to selective COX-2 inhibitor
  3. pharmacological treatment
127
Q

first line medications for NSAID-induced PUD

A

PPI
H2RA
sucralfate

128
Q

3 antacid medication

A

calcium-carb
mag salts
aluminum salts

129
Q

SE of antacids (6)

A

rebound hyperacidity
diarrhea (mag)
constipation (alum)
nausea
stomach pain
hypercalcemia

130
Q

contraindications of antacids

A

none

131
Q

instructions for antacids

A

take 1-4 hours after iron, sulfonylureas, tetracyclines, and quinolones
symptom relief only, doesn’t heal ulcers

132
Q

first line treatment hepatic encephalopathy

A

lactulose oral or rectal

133
Q

second line treatment hepatic encephalopathy

A

rifaximin

134
Q

third line treatment hepatic encephalopathy

A

miralax

135
Q

treatment recommendation for mild UC

A

PO and rectal aminosalicylates

136
Q

treatment recommendation for mod UC

A

add steroid

137
Q

treatment recommendation for severe UC

A

hospitalization

138
Q

treatment for mild Crohn’s

A

oral/rectal amiosalicylate OR
rectal steroid

139
Q

treatment for mod Crohn’s

A

PO and rectal aminosalicylate AND short term steroids

140
Q

treatment for severe Crohn’s

A

IV steroids and/or IV cyclosporine

141
Q

treatment for fulminant Crohn’s (3)

A

IV steroids and/or IV cyclosporine
IV infliximab or SC adalimumab
supportive care (IVF, bowel rest, TPN)

142
Q

goals of management of inflammatory bowel disease (7)

A
  1. resume normal ADLs
  2. restore general physical/mental well-being
  3. maintain appropriate nutritional status
  4. maintain remission
  5. decrease frequency and severity of exac.
  6. decrease med SE
  7. increase life expectancy
143
Q

2 aminosalicylates

A

azulfidine
mesalamine

144
Q

MOA of aminosalicylates

A

decrease inflammation in the GI tract by inhibiting PG synthesis

145
Q

MOA of steroids for CD/UC

A

immunosuppression and PG inhibition

146
Q

3 immunosuppressive agents for CD/UC

A

imuran
puriethnol
rheumatrex

147
Q

MOA of immunosuppressive agents for CD/UC

A

decrease prod. of various inflammatory mediators

148
Q

2 abx used to treat CD/UC

A

flagyl
cipro

149
Q

3 TNFa inhibitors for CD/UC

A

remicade
humira
cimzia

150
Q

MOA of TNFa inhibitors

A

overexpression of immunologic cytokines including TNF seen in CD-> TNF inhibitors neutralize soluble forms of TNF and inhibit its binding to TNF

151
Q

2 selective adhesion molecule inhibitors for CD/UC

A

tysabri
entyvio

152
Q

MOA of selective adhesion molecule inhibitors for CD/UC

A

prevent migration of inflammatory lymphocytes into the gut mucosa

153
Q

ingestion/admin causes of N/V (5)

A

chemo
opiates
abx
NSAIDs
HT

154
Q

how to treat chemo induced N/V (4)

A

benzos
zofran
marinol/dronabinol
steroids

155
Q

GI causes of N/V (2)

A

outlet obstruction
motility disorders

156
Q

how to treat GI induced N/V

A

reglan

157
Q

neuro causes of N/V (4)

A

cerebellar hemorrhage
tumor
hydrocephalus
elevated ICP

158
Q

how to treat neuro causes of N/V (2)

A

surgery
steroids

159
Q

metabolic causes of N/V (4)

A

Addisons
vol. depletion
DKA
hypercalcemia

160
Q

how to treat metabolic causes of N/V

A

treat cause

161
Q

how to treat PONV (2)

A

phenothiazines (compazine)
droperidol

162
Q

how to treat anxiety related N/V

A

benzos

163
Q

how to treat pregnancy related N/V (3)

A

antihistamines
anticholinergics
promethazine

164
Q

how to treat motion sickness (2)

A

antihistamines
anticholinergics

165
Q

first line treatment of N/V

A

phenothiazine

166
Q

second line treatment of N/V

A

antihistamine
anticholinergic

167
Q

third line treatment of N/V

A

re-eval cause

168
Q

3 medications used for motion sickness

A

hydroxyzine
meclizine
dramamine
scopolamine

169
Q

first line treatment of IBS-C

A

linacoltide or lubiprostone +osmotic laxative used to avoid diarrhea

170
Q

second line treatment of IBS-C

A

osmotic laxative

171
Q

third line treatment of IBS-C

A

stimulant laxative short term

172
Q

first line treatment of IBS-D

A

loperamide

173
Q

second line treatment of IBS-D (2)

A

Lomotil for short term
rifaximin for long term

174
Q

constipation first line agent

A

bulk-forming laxative

175
Q

constipation second line agent

A

mag hydroxide
saline laxative

176
Q

constipation third line agent

A

stimulant laxative

177
Q

enema contraindication

A

under 2 y/o

178
Q

length of OTC constipation therapy

A

<7 days in a row

179
Q

how to treat constipation in pregnancy

A

colace safe
avoid castor oil

180
Q

constipation treatment considerations for the elderly

A

risk of electrolyte imbalance with laxative use
eliminate causative agent (antipsychotics, TCAs, Ca)

181
Q

MOA of lomotil

A

decrease GI motility

182
Q

MOA of loperamide

A

opioid receptor agonist acts on myenteric plexus of colon

183
Q

5 types of medications used to treat diarrhea

A

antimotility agents
adsorbents
absorbents
semisynthetic antibiotic
atypical/antisecretory agents

184
Q

2 antimotility agents

A

lomotil
loperamide

185
Q

contraindications of antimotility agents

A

infectious diarrhea
caution in hepatic dys

186
Q

SE of antimotility agents

A

constipation
drowsiness
blurry vision

187
Q

lomotil interactions

A

HTN crisis with MAOIs

188
Q

adsorbent medication

A

kaopectate

189
Q

kaopectate MOA

A

binds to diarrhea and toxins to solidify stool
add a dose after each BM

190
Q

absorbent medication

A

fibercon

191
Q

MOA fibercon

A

absorbs water in the GI tract to make stool less watery

192
Q

semisynthetic antibiotic medication

A

rifaximin

193
Q

indications for rifaximin for diarrhea

A

noninvasive strains of e.coli
best for travelers diarrhea

194
Q

contraindications for rifaximin

A

hypersensitivity

195
Q

SE of rifaximin (6)

A

peripheral edema
nausea
fatigue
dizziness
HA
muscle spasm

196
Q

how to treat diarrhea in peds

A

oral rehydration is priority
antidiarrheal agents not recommended

197
Q

lomotil age limits

A

not for children under 4

198
Q

indications for laxative use

A

lifestyle modifications fail
eliminated secondary cause

199
Q

lifestyle modifications for constipation

A

diet
exercise
bowel training

200
Q

subsalicylate medication

A

pepto bismol
kaopectate

201
Q

contraindications of subsalicylates

A

hypersensitivity to ASA
kids with flu or chicken pox (Reye syndrome)

202
Q

SE of subsalicylates (3)

A

black stool
dark tongue
tinnitus

203
Q

subsalicylates interaction

A

warfarin

204
Q

first line agents for IBS in pregnant women

A

colace and bulk forming agents (not absorbed systemically)

205
Q

lactulose ok in pregnancy?

A

yes

206
Q

sorbitol ok in pregnancy?

A

yes

207
Q

stimulant laxatives ok in pregnancy?

A

only occasionally if necessary

208
Q

castor oil ok in pregnancy?

A

no
risk of uterine contractions

209
Q

mineral oil ok in pregnancy?

A

no
inhibits vitamin absorption

210
Q

long term SE of PPIs

A

dementia
osteoporosis

211
Q

first line treatment for GERD and length (2)

A

PPI 8-12 wks
diet and lifestyle mod.

212
Q

treatment for hot flashes

A

paxil

213
Q

rome 3 criteria

A

At least three months, with onset at least six months previously, of recurrent abdominal pain or discomfort associated with two or more of the following:

Improvement with defecation; and/or

Onset associated with a change in frequency of stool; and/or

Onset associated with a change in form (appearance) of stool.